Invention Grant
![Imidazo[1,2-a]quinoxalines and derivatives thereof for the treatment of cancer](/docs/US/2020-06-23/US10689384B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[1,2-a]quinoxalines and derivatives thereof for the treatment of cancer
-
Application No.: US15541056Application Date: 2015-12-30
-
Publication No.: US10689384B2Publication Date: 2020-06-23
- Inventor: Carine Deleuze-Masquefa , Pierre-Antoine Bonnet , Pierre Cuq , Cindy Patinote
- Applicant: Universite de Montpellier , Centre National de la Recherche Scientifique (CNRS) , Axlr, Satt du Languedoc Roussillon
- Applicant Address: FR Montpellier FR Paris FR Montpellier
- Assignee: Universite de Montpellier,Centre National de la Recherche Scientifique (CNRS),Axlr, Satt du Languedoc Roussillon
- Current Assignee: Universite de Montpellier,Centre National de la Recherche Scientifique (CNRS),Axlr, Satt du Languedoc Roussillon
- Current Assignee Address: FR Montpellier FR Paris FR Montpellier
- Agency: Banner & Witcoff, Ltd.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@565672b8
- International Application: PCT/EP2015/081397 WO 20151230
- International Announcement: WO2016/107895 WO 20160707
- Main IPC: C07D487/04
- IPC: C07D487/04
![Imidazo[1,2-a]quinoxalines and derivatives thereof for the treatment of cancer](/abs-image/US/2020/06/23/US10689384B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to imidazo[1,2-a]quinoxaline compounds of formula (I) for the treatment of cancer, the pharmaceutical compositions comprising said chemical compounds, and the therapeutic uses thereof.
Public/Granted literature
- US20180016278A1 Imidazo[1,2-a]quinoxalines and Derivatives Thereof for the Treatment of Cancer Public/Granted day:2018-01-18
Information query
